146 related articles for article (PubMed ID: 19775911)
1. Goals of stability evaluation throughout the vaccine life cycle.
Krause PR
Biologicals; 2009 Nov; 37(6):369-78; discussion 421-3. PubMed ID: 19775911
[TBL] [Abstract][Full Text] [Related]
2. Vaccine stability study design and analysis to support product licensure.
Schofield TL
Biologicals; 2009 Nov; 37(6):387-96; discussion 421-3. PubMed ID: 19717312
[TBL] [Abstract][Full Text] [Related]
3. Maintenance of vaccine stability through annual stability and comparability studies.
Schofield TL
Biologicals; 2009 Nov; 37(6):397-402; discussion 421-3. PubMed ID: 19717311
[TBL] [Abstract][Full Text] [Related]
4. Basic principles of stability.
Egan W; Schofield T
Biologicals; 2009 Nov; 37(6):379-86; discussion 421-3. PubMed ID: 19720547
[TBL] [Abstract][Full Text] [Related]
5. Consideration on a few aspects of the stability studies post licensure.
Pierard I; Spelte G; Le Tallec D; Duchêne M
Biologicals; 2009 Nov; 37(6):403-6; discussion 421-3. PubMed ID: 19853472
[TBL] [Abstract][Full Text] [Related]
6. Stability post-licensure: compatibility container content - a practical case study.
Duchêne M; Jeanmart L; Slegers B
Biologicals; 2009 Nov; 37(6):407-9; discussion 421-3. PubMed ID: 19717309
[TBL] [Abstract][Full Text] [Related]
7. Stability of vaccines - bridging from stability data to continuous safety and efficacy throughout shelf life - an always reliable approach?
Pfleiderer M
Biologicals; 2009 Nov; 37(6):364-8. PubMed ID: 19773184
[TBL] [Abstract][Full Text] [Related]
8. Stability testing of vaccines: Developing Countries Vaccine Manufacturers' Network (DCVMN) perspective.
Jadhav SS; Dogar V; Gautam M; Gairola S
Biologicals; 2009 Nov; 37(6):360-3. PubMed ID: 19717310
[TBL] [Abstract][Full Text] [Related]
9. Guidelines on stability evaluation of vaccines.
Dobbelaer R; Pfleiderer M; Haase M; Griffiths E; Knezevic I; Merkle A; Hongzhang Y; Candrian U; Castillo MA; Wood D; Daviaud J; Dellepiane N; Hernandez CA; Lambert S; Shin J-; Knezevic I; Daviaud J; Fournier-Caruna J; Kopp S; Zhou T; Zaffran M; Bektimirov TA; Cooper G; da Silveira SC; Egan W; Medveczky N; Morris T; Griffiths E; Nunez YH; Horiuchi Y; Jivapaisarnpong T; Krause P; Martin J; Southern J; Tyas Utami AR; Jadhav S; Susanti I; Yamaguchi IK; Duchene M; Laschi A; Schofield TL;
Biologicals; 2009 Nov; 37(6):424-34; discussion 421-3. PubMed ID: 19875304
[No Abstract] [Full Text] [Related]
10. Stability evaluation of vaccines: WHO approach.
Knezevic I
Biologicals; 2009 Nov; 37(6):357-9; discussion 421-3. PubMed ID: 19729320
[TBL] [Abstract][Full Text] [Related]
11. An annual vaccine: seasonal influenza.
Jivapaisarnpong T; Krause PR
Biologicals; 2009 Nov; 37(6):410-1; discussion 421-3. PubMed ID: 19850497
[TBL] [Abstract][Full Text] [Related]
12. Robustness testing in pharmaceutical freeze-drying: inter-relation of process conditions and product quality attributes studied for a vaccine formulation.
Schneid SC; Stärtzel PM; Lettner P; Gieseler H
Pharm Dev Technol; 2011; 16(6):583-90. PubMed ID: 21563990
[TBL] [Abstract][Full Text] [Related]
13. A vaccine measured with a highly variable assay: rabies.
Jivapaisarnpong T; Schofield T; Krause PR
Biologicals; 2009 Nov; 37(6):412-5; discussion 421-3. PubMed ID: 19846319
[TBL] [Abstract][Full Text] [Related]
14. Vaccine industry perspective of current issues of good manufacturing practices regarding product inspections and stability testing.
Monahan TR
Clin Infect Dis; 2001 Dec; 33 Suppl 4():S356-61. PubMed ID: 11709773
[TBL] [Abstract][Full Text] [Related]
15. Regulatory requirements for veterinary vaccine stability in the European Community.
Fawthrop D
Dev Biol Stand; 1996; 87():319-27. PubMed ID: 8854032
[TBL] [Abstract][Full Text] [Related]
16. Monitoring the stability of human vaccines.
Fairweather WR; Mogg R; Bennett PS; Zhong J; Morrisey C; Schofield TL
J Biopharm Stat; 2003 Aug; 13(3):395-413. PubMed ID: 12921389
[TBL] [Abstract][Full Text] [Related]
17. Stability of influenza sub-unit vaccine. Does a couple of days outside the refrigerator matter?
Coenen F; Tolboom JT; Frijlink HW
Vaccine; 2006 Jan; 24(4):525-31. PubMed ID: 16150515
[TBL] [Abstract][Full Text] [Related]
18. Regulatory practices and problems with vaccine stability studies and the establishment of shelf lives.
Fenyves A
Dev Biol Stand; 1996; 87():329-33. PubMed ID: 8854033
[TBL] [Abstract][Full Text] [Related]
19. FDA perspective on specifications for biotechnology products--from IND to PLA.
Murano G
Dev Biol Stand; 1997; 91():3-13. PubMed ID: 9413677
[TBL] [Abstract][Full Text] [Related]
20. Vaccines in the national immunization programme.
Bass AG
P N G Med J; 1993 Jun; 36(2):141-57. PubMed ID: 8154196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
